Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2006-08-28

FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin from Prasco Laboratories, resulting in labeling and post-a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Atorvastatin (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)